In April 2021, The National Institute for Health and Care Excellence (NICE) released new guidance on the management of chronic pain.
In The British Pain Society's (BPS) initial statement on the NICE guideline, they conclude:
"In summary, the new NICE guideline NG193 acknowledges that individual and indeed specialised chronic pain assessment and management is required. However, The British Pain Society feels that the guidance as it stands could lead to the withdrawal of supervised short-term therapies which can work safely in carefully selected and monitored patients with forms of chronic primary pain."
Follow the link below to access the statement in full.